Publication: Cutaneous adverse reactions to fluoroquinolones
Issued Date
2011-06-01
Resource Type
ISSN
17103568
Other identifier(s)
2-s2.0-79957606087
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Dermatitis. Vol.22, No.3 (2011), 155-160
Suggested Citation
Kanokvalai Kulthanan, Leena Chularojanamontri, Araya Manapajon, Naruemon Dhana, Kowit Jongjarearnprasert Cutaneous adverse reactions to fluoroquinolones. Dermatitis. Vol.22, No.3 (2011), 155-160. doi:10.2310/6620.2011.10115 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/12483
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Cutaneous adverse reactions to fluoroquinolones
Other Contributor(s)
Abstract
Background: To date, even though there are some large studies on adverse reactions related to fluoroquinolones, there is no comprehensive study focusing on cutaneous adverse drug reactions associated with their use. Objective: To demonstrate the pattern of cutaneous reaction related to the administration of each type of fluoroquinolone and to study the cross-sensitivity between various types of fluoroquinolones. Methods: Voluntary reports of any adverse events associated with fluoroquinolone use as reported from January 2004 to December 2008 and obtained from the Adverse Drug Reaction Center, Siriraj Hospital, Thailand, were reviewed. Results: Among 166,736 patients who had been treated with fluoroquinolones, the prevalences of adverse reaction and cutaneous adverse reaction were 0.13% and 0.09%, respectively. The prevalence of cutaneous reaction to individual fluoroquinolones varies between 0.04% and 0.37%. One hundred fifty-one subjects were enrolled. Most cutaneous reactions were attributed to ciprofloxacin (n = 93), and the most frequent adverse cutaneous reaction seen was maculopapular rash (39.7%). Thirteen cases (8.6%) involved a previous history of fluoroquinolone hypersensitivity; among these, 15.4% had cross-reactivity potential. Conclusion: These data suggest that individual fluoroquinolones are responsible for different types and frequencies of cutaneous reactions, with some potentiality of cross-reactivity between different generations. © 2011 American Contact Dermatitis Society. All Rights Reserved.